The immunologic and genetic basis of psoriasis
- PMID: 10490116
- DOI: 10.1001/archderm.135.9.1104
The immunologic and genetic basis of psoriasis
Similar articles
-
Reviewing concepts in the immunopathogenesis of psoriasis.An Bras Dermatol. 2011 Nov-Dec;86(6):1151-8. doi: 10.1590/s0365-05962011000600014. An Bras Dermatol. 2011. PMID: 22281904 Review. English, Portuguese.
-
TEAD4 transcriptional regulates SERPINB3/4 and affect crosstalk between keratinocytes and T cells in psoriasis.Immunobiology. 2020 Sep;225(5):152006. doi: 10.1016/j.imbio.2020.152006. Epub 2020 Aug 14. Immunobiology. 2020. PMID: 32962824
-
The cytokine network in psoriasis.Arch Dermatol. 1991 Jun;127(6):871-84. Arch Dermatol. 1991. PMID: 2036036 No abstract available.
-
Immunopathogenesis of psoriasis.Australas J Dermatol. 2006 Aug;47(3):151-9. doi: 10.1111/j.1440-0960.2006.00262.x. Australas J Dermatol. 2006. PMID: 16866993 Review.
-
The role of the T cell in psoriasis and the action of cyclosporin in this disease.Acta Derm Venereol Suppl (Stockh). 1989;146:133-4; discussion 134-5. Acta Derm Venereol Suppl (Stockh). 1989. PMID: 2609854 No abstract available.
Cited by
-
Do eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary study.Clin Cosmet Investig Dermatol. 2011;4:139-43. doi: 10.2147/CCID.S24165. Epub 2011 Aug 29. Clin Cosmet Investig Dermatol. 2011. PMID: 21931499 Free PMC article.
-
Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?Drug Saf. 2006;29(1):49-66. doi: 10.2165/00002018-200629010-00004. Drug Saf. 2006. PMID: 16454534 Review.
-
Skin innate immune system in psoriasis: friend or foe?J Clin Invest. 1999 Nov;104(9):1161-4. doi: 10.1172/JCI8633. J Clin Invest. 1999. PMID: 10545511 Free PMC article. Review. No abstract available.
-
Immunopathogenic mechanisms in psoriasis.Clin Exp Immunol. 2004 Jan;135(1):1-8. doi: 10.1111/j.1365-2249.2004.02310.x. Clin Exp Immunol. 2004. PMID: 14678257 Free PMC article. Review.
-
Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.Drug Des Devel Ther. 2014 Sep 16;8:1405-18. doi: 10.2147/DDDT.S67370. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25258510 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical